Drug Profile
Moriah 1000
Alternative Names: M1K; Moriah-1000Latest Information Update: 26 May 2020
Price :
$50
*
At a glance
- Originator Ensol Biosciences
- Class Antidementias; Peptides
- Mechanism of Action Amyloid beta-protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Alzheimer's disease
Most Recent Events
- 26 May 2020 Preclinical trials in Alzheimer's disease in South Korea (Ensol Biosciences pipeline, May 2020)
- 01 May 2016 Early research in Alzheimer's disease in South Korea (unspecified route)